The Hale family to accelerate pancreatic cancer research and care with one of the biggest gifts ever to the Dana-Farber Cancer Institute


BOSTON–(BUSINESS WIRE) – Continuing their family’s deep commitment to beating pancreatic cancer, Judith B. Hale, her son, Robert T. Hale, Jr., and his wife, Karen Hale, have pledged an additional $ 50 million to Dana- Farber Cancer Institute. This donation, one of the largest one-time gifts in the history of the Institute, will support the Hale Family Center for Pancreatic Cancer Research, founded in 2016 with $ 15 million from Judith, Robert and Karen, and provide cumulative support from the Hale family to Dana-Farber. to over $ 80 million.

This new donation will enable a wide range of ambitious work in two main areas of pancreatic cancer research: early detection and prevention, and precision medicine and biology. Currently a national leader in the field, the Hale Family Center for Pancreatic Cancer Research will launch teams of scientists to harness health system data to identify those most at risk for pancreatic cancer, detect it earlier through new imaging and blood testing approaches, and develop new treatments for pre-invasive and early invasive pancreatic cancer.

The center will also study the biology and interaction of pancreatic cancer cells, the immune system and stromal cells, and will develop a series of clinical trials to test new therapies based on the findings from these initiatives.

“Our intention is to dramatically accelerate the pace of research and new treatments for this terrible disease,” said Judith Hale, member of the board of directors of Dana-Farber. “We invest in the exceptional talent of Dana-Farber because we are committed to finding a cure. It would be a wonderful honor for my husband and a legacy for our family.

“By working in partnership with the Hale family, we have already made significant progress against pancreatic cancer,” said Laurie H. Glimcher, MD, President and CEO of Dana-Farber. “Yet far too many families are still devastated by this disease. We share the Hale family’s bold vision to end pancreatic cancer and save lives, here and around the world. With this incredibly generous and transformational donation, the Hale family offers us an unprecedented opportunity and responsibility to do just that.

“Over 60,000 people will be diagnosed with pancreatic cancer this year, far too often at an advanced stage,” said Karen Hale. “It is essential to detect it early when it is most vulnerable and to have newer and more advanced treatments available when we do. Dana-Farber has the best team of scientists and clinicians to do this urgent work. ”

A generational heritage

This gift is in honor of the late husband of Judith Hale, and of Robert Hale, Jr.’s father, Robert T. “Bob” Hale, Sr., a patient of the Institute, who passed away in 2008. Long-time supporters of the Institute, Robert Sr. and Judith Hale established the Robert T. Hale Sr. and Judith B. Hale Fund for Pancreatic Cancer Research in Dana-Farber in 2007.

The Hale family’s commitment to research and care has continued through the generations. Judith Hale established the Hale Family Center for Pancreatic Cancer in 2012, and together with Robert Jr. and Karen, created the current Hale Family Center for Pancreatic Cancer Research in 2016.

Additionally, Hales’ company, Granite Telecommunications, and its employees have supported research at Dana-Farber and other institutions by providing millions of dollars through corporate philanthropy and popular annual events.

“I am inspired by the Hales’ determination and commitment to the mission we all share,” said Josh Bekenstein, Chairman of the Board of Dana-Farber. “They are a role model to others of the bold, forward-thinking philanthropy that has meant so much progress for patients throughout Dana-Farber’s history.

The Hale Family Center for Pancreatic Cancer Research

“With this extremely generous donation from the Hale family, we have an incredible opportunity to transform the way pancreatic cancer is diagnosed and treated,” said Brian Wolpin, MD, MPH, director of the Hale Family Center for Pancreatic Cancer Research and by Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber. “We share their deep commitment to ending pancreatic cancer, and the entire Hale Center team is extremely grateful – and energized by – their trust and long-standing financial support.

The Hale Family Center for Pancreatic Cancer and the Hale Family Center for Pancreatic Cancer Research include scientists exploring germline genetics, functional genomics, chemical biology, computational biology, cancer metabolism, immunotherapy, and cancer systems development. laboratory models, as well as clinicians specializing in medical oncology, radiation oncology, radiology, pathology, gastroenterology and clinical trial management. This highly collaborative research environment has already had many successes, including:

  • Contributions to the first approval of a targeted drug for patients with pancreatic cancer.

  • Creation of a comprehensive early detection program for patients at hereditary risk of pancreatic cancer which is a national model.

  • Discovery of a new gene for inherited pancreatic cancer by studying families prone to pancreatic cancer.

  • Detailed genetic studies that contributed to national guidelines that now recommend inherited genetic testing and tumor DNA sequencing for all patients with a new diagnosis of pancreatic cancer

  • Completion of the most comprehensive map of the pancreatic cancer immune microenvironment documented to date.

  • Establishment of one of the world’s most advanced clinical trial programs for pancreatic cancer.

About the Dana-Farber Cancer Institute

Dana-Farber Cancer Institute is one of the world’s leading centers for cancer research and care. Dana-Farber’s mission is to reduce the burden of cancer through scientific research, clinical care, education, community engagement and advocacy. The Institute provides the latest cancer treatments for adults through Dana-Farber / Brigham and Women’s Cancer Center, and for children through Dana-Farber / Boston Children’s Cancer and Blood Disorders Center. Dana-Farber is the only hospital in the country with a top 6 US News and World Report Best ranking of cancer hospitals in adult and pediatric care.

As a global leader in oncology, Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the findings of discovery into new treatments for patients locally and across the world. worldwide, and offering more than 1,100 therapeutic and non-therapeutic. clinical tests.


About Hector Hedgepeth

Check Also

Dr. Vizarath Rasool Khan’s free mega medical camp ended successfully

Hyderabad: Dr. Vizarath Rasool Khan’s Free Mega Medical Camp at Shadan Hospital successfully ended on …

Leave a Reply

Your email address will not be published.